The successful candidate will hold a clinical non-tenure track position with the Faculty of Medicine’s Department of Medicine, one of its affiliated hospitals (e.g., The Ottawa Hospital, Children’s Hospital of Eastern Ontario, Hôpital Montfort, The Royal Ottawa, Élisabeth Bruyère Hospital), and its respective affiliated research institute (The Ottawa Hospital Research Institute (OHRI); Children’s Hospital of Eastern Ontario Research Institute (CHEO-RI); University of Ottawa Heart Institute (UOHI); Bruyere Research Institute (BRI); Institute of Mental Health Research (IMHR); or The Institut du Savoir Montfort). The Chairholder will hold, or will be eligible to hold a licence to practice medicine with the College of Physician and Surgeons of Ontario (CPSO).
We are interested in attracting early-career candidates with demonstrated strengths in acute stroke management. This research will directly improve the health of the community served by the University of Ottawa and beyond through the identification of novel treatments and methods for stroke. In addition to clinical training, it is expected that the incumbent researcher will have formal graduate training and expertise in stroke clinical research and trials. We are interested in researchers with demonstrated strengths in areas that may include but are not limited to:
- Addressing current and future health needs of stroke patients in Canada and worldwide, including developing and implementing effective interventions to improve the short- and long-term outcomes for patients with stroke;
- Developing innovative methods and strategies in the clinical design of stroke clinical trials;
- Conducting thrombolytic and thrombectomy research and imaging-based patient selection for trials;
- Leading or facilitating phase 2 and 3 multi-centre clinical trials of novel acute stroke therapies;
- Seeking and maintaining meaningful international collaborations in stroke research;
- Attracting competitive Canadian and international trainees.
The successful candidate will become an integral part of a dynamic, collaborative, and interconnected research environment in the Faculty of Medicine and its associated Research Institutes. As Chair, the researcher will also directly contribute to development of clinical trials to designed to improve the survival or quality of life of stroke patients.
Tier 2 Canada Research Chairs, tenable for five years and renewable once, are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field. For each Tier 2 Chair, the institution receives $100,000 annually for five years, with an additional $20,000 annual research stipend for first-term Tier 2 Chairs.
Candidates should, at a minimum, be assistant or associate professors, or possess the necessary qualifications to be appointed to these levels. Candidates who are more than 10 years from their highest degree must contact the University of Ottawa directly for questions related to their potential eligibility for a Tier 2 Chair. The institution may nominate a professor or a researcher who is more than 10 years from their highest degree at the time of nomination and has experienced legitimate career interruptions (see acceptable justifications). In such cases, the institution must submit to the Secretariat a formal justification (using the Tier 2 Justification Screening Form), explaining why the nominee is still considered to be an emerging scholar. The University recognizes the legitimate impact that leaves (e.g., parental leave, leave due to illness) can have on a candidate’s record of research achievement and that these leaves will be taken into careful consideration during the assessment process. New CRC nominees are also eligible for infrastructure support from the Canada Foundation for Innovation (CFI) to help acquire state-of-the-art equipment essential to their work.